Modern age pathology of pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Modern age pathology of pulmonary arterial hypertension.

Modern age pathology of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37457479

about

Microarray analysis in pulmonary hypertension Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis Role of Sphingolipids in the Pathobiology of Lung Inflammation Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series)Inflammatory cytokines in pulmonary hypertension Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats Recent advances in the management of pulmonary arterial hypertension From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial.Pediatric pulmonary arterial hypertension.Gender, Estrogen, and Obliterative Lesions in the Lung.Sex differences in the pulmonary circulation: implications for pulmonary hypertension Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Pulmonary hypertension's variegated landscape: a snapshot.Right ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertension.Leptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice.Subcellular mechanisms in pulmonary arterial hypertension: combinatorial modalities that inhibit anterograde trafficking and cause bone morphogenetic protein receptor type 2 mislocalization.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension.Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Diverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype.NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.Sex-dependent influence of endogenous estrogen in pulmonary hypertension.Sublingual microcirculation in pulmonary arterial hypertension.Pulmonary hypertension and the right ventricle-thinking outside the box (Third International Right Heart Failure Summit, part 1).The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension.BMP pathway regulation of and by macrophages.Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension.Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension High-mobility group box-1 induces vascular remodelling processes via c-Jun activation Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients Epoprostenol sodium for treatment of pulmonary arterial hypertension.

P2860

Q26748607-07F2BF6B-46FF-46BF-B7A9-2587EBFFBA4C Q26749091-A27DEB16-CCCE-49D9-AC28-58FAD127CAA7 Q26771956-AC6E6F25-D1BE-4901-B907-6D17143F09F7 Q26772286-019B9930-A8D1-481A-818C-7148516B5FB9 Q27007510-39726CDD-5D32-495D-9C83-1A3E2F78E9D0 Q27026465-2A6D2BDA-1F6C-4932-952D-2C45E417B83F Q27313498-171F1911-0B5D-4BD1-B474-0F7F85EA0387 Q28075707-449E5218-AF0C-4265-AF16-CBA3572EDE32 Q28076273-86E07DCE-855B-47BB-ADE1-488CA3DF33D4 Q28078976-3FAD8552-8AB7-47CD-925C-FD6C365127BB Q28544637-0AA0BE81-92DA-46B9-9258-F1297E3ABCDA Q30539790-C6A3D0B7-0C6B-4C36-BD1E-3237C1BE2EEB Q30851205-64D4A7B5-F792-49E3-9322-4DBF13F3FEAF Q33163446-B5F9DB3D-6740-4779-8DD2-61DAEDF947ED Q33567156-41F832D5-6E6C-4DCD-B983-6F5EACD94284 Q33568826-99A48DBD-63E3-4B7E-9CB0-C5A5DFA24040 Q33608219-82ED529A-3304-4C0D-8311-D6AF135EA5B2 Q33738561-2BA5E2F3-E8A9-49A0-91CA-F0164E2437AE Q33788521-407FC47D-CEA0-4CFF-A227-2D0E6EB98326 Q33803046-74448881-CCFB-4EC6-AD58-1973C43EB706 Q33806134-C20CA625-63DD-4E6C-B5CE-14959B0FD81B Q33898213-A4D136C7-92D9-428F-BB6C-1D0E0CB55AE5 Q33901696-760FD029-CAFB-4BC9-AF36-C640D7CED095 Q33909537-7AD9F6FF-44A5-4A8B-B47C-E5B03CC2EC1A Q33956819-99A3B4B7-332E-4D15-998A-D32DF5249D81 Q34001699-27182A6B-8993-4616-A6A7-6075F4792B30 Q34025109-D02ADDDB-8D39-4FA0-B00D-F4E0A2468CAB Q34425976-4E79D808-DBF7-49C1-BEDF-709AF0632019 Q34479198-B2C99FF3-C9EE-41E2-A221-CC17D6170F9A Q34782622-752815BC-7729-4AB3-A7C5-BD3611DBEAC4 Q34924892-25862098-EDC3-4015-8215-B777B651CB9A Q34958933-B3FFCEC7-2249-40EE-A7F9-3FAE0CDA12BB Q34987884-408EFFAB-26E3-42F4-BA38-04BBE021A57E Q35061559-660203BD-C997-4D66-AF8C-8E7BFE2D2C39 Q35142695-5B6C462A-2B85-4B63-9268-41BFD74C5FB1 Q35185482-0B9A3C97-CE93-4F78-9E1A-A13E7DDE49AB Q35517559-E8A49C85-DD52-4EB6-B357-E0AF2AC030AC Q35571972-03DEA338-7347-44AC-85D2-B11639A12EA2 Q35595010-F515F70E-B4EB-428F-A043-BD9383AB4A20 Q35624220-9EAE27D6-976E-47BC-B3EB-11E34A7B2ABA

P2860

Modern age pathology of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37457479

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modern age pathology of pulmonary arterial hypertension.

@en

Modern age pathology of pulmonary arterial hypertension.

@nl

type

label

Modern age pathology of pulmonary arterial hypertension.

@en

Modern age pathology of pulmonary arterial hypertension.

@nl

prefLabel

Modern age pathology of pulmonary arterial hypertension.

@en

Modern age pathology of pulmonary arterial hypertension.

@nl

P1433

Q37457479-E747BB99-A8D1-42E4-AA9F-A6AC13F0B00D

P1476

Q37457479-9E66BD43-1AC1-4E29-AE24-FF06A0F77028

P2093

Q37457479-03C12651-C35F-4817-BDD8-EA393AA4F812

Q37457479-120901BD-449E-4E83-8EEE-BC1442534810

Q37457479-335E77F9-7C32-413C-8217-7B32740F36FB

Q37457479-349D6A89-2479-492D-A467-E70B51B7F0B3

Q37457479-56738320-5957-43AD-B15D-8E7591902D0D

Q37457479-607CEDC6-3583-4A76-A51E-DE14813894CD

Q37457479-60E816AD-7117-4A02-92CB-E69544329227

Q37457479-7C9F97F0-3B7A-4C63-9352-5C4ACDAF9FA8

Q37457479-BC81A58E-65CC-421B-AA06-3F538619C3AC

Q37457479-F1E514C9-E2A8-4C81-99AD-2800ACC47642

P2860

Q37457479-006553E0-2819-4450-B8CD-79D2D08B634D

Q37457479-2783B779-0602-408C-AA05-4B901912B454

Q37457479-37C62FD7-E8D6-49F2-96CB-13215ECCFA4C

Q37457479-4B4F91DA-B8D5-49CE-A592-30CF10496F70

Q37457479-5D1069CF-C38E-4BFC-93C4-E18D919B5B98

Q37457479-6FB4F48E-0872-4BD4-B24D-08D92043580C

Q37457479-71B9D710-80F6-4832-BDB9-53506310DBAA

Q37457479-80088F53-2422-4D57-985F-79B044797F57

Q37457479-804821B3-A2ED-498D-86E5-36EF8D7AAEFC

Q37457479-8A7AAA7E-AA80-4E78-8822-7D86F32DD7BD

P304

Q37457479-ECDBEC6E-FA47-4D6D-9D88-9B896A5794A7

P31

Q37457479-07244217-F53E-4D4D-AFD4-1B6D7872715C

P356

Q37457479-1456A0A7-5CFB-40D8-B1CB-255531CEDA21

P407

Q37457479-7DA77A1B-99A5-43B1-828E-C31897129C64

P433

Q37457479-9D41A245-1560-4F4C-882E-FA5EB0A30E8F

P478

Q37457479-06586F9E-1641-4090-A338-80B975031E0A

P577

Q37457479-B0203C0D-FC9B-4E5E-A0F5-A64C8E0700A3

P698

Q37457479-30E73B73-EDCB-4DB4-B064-E99E7C92B631

P921

Q37457479-3391ef8b-9725-48b3-89bb-f836fea5615e

Q37457479-556B2DB3-6A56-4DFB-B6C9-476611F1770B

P932

Q37457479-5939300C-A311-4298-9191-C8AA8E696599

P356

RCCM.201201-0164OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Modern age pathology of pulmonary arterial hypertension.

@en

P2093

Aneta Gandjeva

http://www.w3.org/2001/XMLSchema#string

Brian B Graham

http://www.w3.org/2001/XMLSchema#string

Carlyne D Cool

http://www.w3.org/2001/XMLSchema#string

Elvira Stacher

http://www.w3.org/2001/XMLSchema#string

James M Hunt

http://www.w3.org/2001/XMLSchema#string

Marsha Jessup

http://www.w3.org/2001/XMLSchema#string

Michaela A Aldred

http://www.w3.org/2001/XMLSchema#string

Rubin M Tuder

http://www.w3.org/2001/XMLSchema#string

Steve D Groshong

http://www.w3.org/2001/XMLSchema#string

Vallerie V McLaughlin

http://www.w3.org/2001/XMLSchema#string

P2860

An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure.

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension

Treatment of pulmonary arterial hypertension.

Pathology of pulmonary arterial hypertension.

Pulmonary changes in congenital heart disease with Down's syndrome: their significance as a cause of postoperative respiratory failure.

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study.

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension.

P304

261-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201201-0164OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22679007

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3886716

http://www.w3.org/2001/XMLSchema#string